Free Trial
OTCMKTS:MAHLY

MediPal (MAHLY) Stock Price, News & Analysis

$18.15
-0.92 (-4.82%)
(As of 09/16/2024 ET)

About MediPal Stock (OTCMKTS:MAHLY)

Key Stats

Today's Range
$18.15
$18.15
50-Day Range
$14.86
$19.07
52-Week Range
$14.29
$19.07
Volume
250 shs
Average Volume
578 shs
Market Capitalization
N/A
P/E Ratio
0.19
Dividend Yield
125.66%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Further, the company trades in medical clerks; outsourcing of medical administrative, and medical consulting; and distributes specialty pharmaceuticals. Additionally, it engages in contract logistics services, as well as offers information provision services. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. The company was founded in 1898 and is headquartered in Tokyo, Japan.

MediPal Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks

Overall MarketRank™: 29th Percentile

MediPal scored higher than 29% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of MediPal is 0.19, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 135.61.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of MediPal is 0.19, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 146.17.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    MediPal has a short interest ratio ("days to cover") of 8.
  • Change versus previous month

    Short interest in MediPal has recently decreased by 55.56%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    MediPal pays a meaningful dividend of 1.92%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    MediPal does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of MediPal is 23.88%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about MediPal's dividend.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    MediPal has a short interest ratio ("days to cover") of 8.
  • Change versus previous month

    Short interest in MediPal has recently decreased by 55.56%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    MediPal has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.67 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for MediPal this week, compared to 0 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, MediPal insiders have not sold or bought any company stock.

  • Percentage Held by Institutions

    Only 0.07% of the stock of MediPal is held by institutions.

  • Read more about MediPal's insider trading history.
Receive MAHLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MediPal and its competitors with MarketBeat's FREE daily newsletter.

MAHLY Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

MAHLY Stock Analysis - Frequently Asked Questions

MediPal's stock was trading at $16.40 at the beginning of 2024. Since then, MAHLY shares have increased by 10.7% and is now trading at $18.15.
View the best growth stocks for 2024 here
.

Shares of MAHLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Distribution
Sub-Industry
N/A
Current Symbol
OTCMKTS:MAHLY
CIK
N/A
Fax
N/A
Employees
12,795
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (OTCMKTS:MAHLY) was last updated on 9/17/2024 by MarketBeat.com Staff
From Our Partners